Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Lexicon Pharmaceuticals

Biotech & Life Sciences · The Woodlands, United States · Founded 1995 · IPO 1998 Thoroughbred

Biopharmaceutical company that has harnessed the power of genetics for drug discovery

Valuation
$653M
Market cap · May/2026
Revenue
$50M
Latest reported FY
Featured in $10B+ revenueThoroughbred · Power Law outcome

Investors

2 investors on Lexicon Pharmaceuticals's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 2 investors entered at this stage
Baylor College of Medicine
NEA

Lexicon Pharmaceuticals mafia

Startups founded by Lexicon Pharmaceuticals alumni

Former Lexicon Pharmaceuticals employees who went on to start their own companies. Sorted by Dealroom signal score.

KymabEst. 2010
Allan BradleyUnited Kingdom
Signal score62
LeadArt TechnologiesEst. 2017
JYJie YanUnited States
Signal score52
Inherent BiosciencesEst. 2019
AOAndy OlsonUnited States
Signal score46
4M TherapeuticsEst. 2020
Pablo LapuertaUnited States
Signal score40

Book a demo to explore the full alumni network →

Global footprint

Where Lexicon Pharmaceuticals has talent and traffic

Workforce by country
3 countries with
team presence
🇺🇸 United States97.8%
🏳️ Trinidad and Tobago0.8%
🇵🇰 Pakistan0.8%
3 countries shown
Web traffic by country
8.9K monthly visits
across markets
🇺🇸 United States61.8%
🇮🇳 India30.3%
🇯🇵 Japan7.9%
🇬🇧 United Kingdom0%
🇵🇰 Pakistan0%
Top 5 markets shown

Market sentiment

What the market is saying about Lexicon Pharmaceuticals

An AI-synthesized read of the highest-engagement posts about Lexicon Pharmaceuticals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Lexicon Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles